Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT
Kymera Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 44.71M | 58.88M | 47.07M | 87.56M | 88.55M | 79.41M | 78.59M | 46.85M | 51.67M | 46.67M | 46.83M | 45.96M | 56.75M | 63.75M | 72.83M | 70.34M | 64.54M | 49.31M |
Cost of Revenue | 8.11M | 6.02M | 3.97M | 2M | 900K | 1.8M | 2.7M | 3.52M | 46.49M | 46.3M | 45.4M | 44.58M | 700K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 42.63M | 58.88M | 47.07M | 87.56M | 87.65M | 77.61M | 75.89M | 43.33M | 5.17M | 375K | 1.43M | 1.39M | 56.05M | 63.75M | 72.83M | 70.34M | 64.54M | 49.31M |
Operating Income | -311.86M | -278.23M | -261.63M | -200.19M | -185.58M | -178.03M | -165.53M | -184.85M | -172.22M | -169.65M | -161.26M | -156.62M | -140.38M | -124.3M | -100.53M | -79.32M | -58.76M | -48.23M |
Interest Income | 36.73M | 37.6M | 38.03M | 32.96M | 27.95M | 23.65M | 18.76M | 17.59M | 14.82M | 10.79M | 6.62M | 2.94M | 1.15M | 657K | 485K | 465K | 465K | 595K |
Pretax Income | -275.43M | -240.88M | -223.86M | -167.47M | -157.85M | -154.59M | -146.96M | -167.46M | -157.59M | -159.05M | -154.81M | -153.84M | -139.42M | -123.83M | -100.22M | -79M | -58.41M | -47.73M |
Net Income | -275.43M | -240.88M | -223.86M | -167.47M | -157.85M | -154.59M | -142.62M | -162.3M | -152.43M | -153.34M | -153.19M | -153.04M | -138.62M | -123.58M | -100.22M | -79M | -58.41M | -47.73M |
Selling & General & Admin | 65.7M | 65.43M | 63.53M | 61.43M | 60.09M | 56.85M | 55.04M | 52.45M | 48.89M | 45.79M | 43.84M | 43.94M | 44.05M | 41.05M | 36.34M | 29.78M | 25.95M | 21.58M |
Research & Development | 290.87M | 271.68M | 240.25M | 221.4M | 209.11M | 195.67M | 189.08M | 179.24M | 175M | 170.53M | 164.25M | 158.64M | 153.07M | 147M | 137.02M | 119.88M | 97.35M | 75.95M |
Other Expenses | -2.08M | n/a | 4.92M | 4.92M | 4.92M | 4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 354.49M | 337.12M | 308.71M | 287.75M | 274.13M | 257.45M | 244.12M | 231.69M | 223.89M | 216.32M | 208.08M | 202.58M | 197.12M | 188.05M | 173.36M | 149.66M | 123.3M | 97.53M |
Interest Expense | 299K | 252K | 249K | 242K | 223K | 210K | 196K | 202K | 197K | 190K | 176K | 168K | 202K | 189K | 172K | 149K | 107K | 104K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 356.57M | 337.12M | 308.71M | 287.75M | 274.13M | 257.45M | 244.12M | 231.69M | 223.89M | 216.32M | 208.08M | 202.58M | 197.12M | 188.05M | 173.36M | 149.66M | 123.3M | 97.53M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -4.34M | -5.16M | -5.16M | -5.71M | -1.62M | -751K | -626K | 25K | 392K | 341K | 216K | 118K |
Shares Outstanding (Basic) | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
Shares Outstanding (Diluted) | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
EPS (Basic) | -3.47 | -3.1 | -2.97 | -2.34 | -2.42 | -2.51 | -2.45 | -2.79 | -2.68 | -2.78 | -2.86 | -2.93 | -2.7 | -2.48 | -2.06 | -1.69 | -1.31 | -1.08 |
EPS (Diluted) | -3.47 | -3.1 | -2.97 | -2.34 | -2.42 | -2.51 | -2.45 | -2.79 | -2.68 | -2.78 | -2.86 | -2.93 | -2.7 | -2.48 | -2.06 | -1.69 | -1.31 | -1.08 |
EBITDA | -277.16M | -232.67M | -216.24M | -160.98M | -152.47M | -150.25M | -143.2M | -163.74M | -154.01M | -155.68M | -151.65M | -150.82M | -136.46M | -121.03M | -97.65M | -76.65M | -56.27M | -45.77M |
EBIT | -275.13M | -240.63M | -223.61M | -167.23M | -157.63M | -154.38M | -146.77M | -167.26M | -157.4M | -158.86M | -154.63M | -153.67M | -139.22M | -123.64M | -100.04M | -78.85M | -58.3M | -47.63M |
Depreciation & Amortization | 8.11M | 7.96M | 7.37M | 6.25M | 5.16M | 4.13M | 3.56M | 3.52M | 3.38M | 3.78M | 3.86M | 3.73M | 3.64M | 2.89M | 2.4M | 2.21M | 2.02M | 1.86M |